Research

FDA approved Biogen’s Qalsody for treatment of SOD1-ALS.
Blog Post

FDA Approves Biogen’s Qalsody for Treatment of SOD1-ALS

By Sujatha Gurunathan | April 25, 2023
Researcher or medical technologist's pipetting samples into glass tubes.
Blog Post

MDA Makes Connections at the University of Minnesota’s Muscle Research Lab Day

By Jordann Hager | April 17, 2023
Banner announcing the Pompe Disease Symposium, with speaker Priya Kishnani, MD, MBBS, at the 2023 MDA Clinical & Scientific Conference in Dallas, Texas. Photo Credit Larry Luxner
Blog Post

At MDA Conference, Pompe Disease Researchers Stressed Importance of Newborn Screening

By Larry Luxner | April 14, 2023
Blog Post

2023 MDA Clinical and Scientific Conference Starts Strong

By Amy Bernstein | March 21, 2023
Blog Post

Quest Podcast: The Changing Landscape of Neuromuscular Care

By MDA Staff | March 15, 2023
3d rendered image shown neuromuscular junction, where nerve end splits into several neural end plates on different muscle cells.
Blog Post

Simply Stated: Research Updates in Facioscapulohumeral Muscular Dystrophy (FSHD)

By Sujatha Gurunathan | February 28, 2023
Men's hand arranging front view wood blocks with healthcare medicine icons
Blog Post

What About My Disease? Why a New Treatment for One Neuromuscular Disease Is Good News for All

By Cheryl Alkon | February 27, 2023
Closeup of an unclothed infant lying on its side on a white blanket while an adult hand holds a stethoscope to its chest.
Featured Article

Q&A: Understanding Congenital Muscular Dystrophy

By MDA Staff | February 16, 2023
Registration sign for MDA conference in lobby room filled with people
Blog Post

MDA 2023 Clinical and Scientific Conference – Q&A

By Mindy Henderson | February 13, 2023
Blog Post

Access to Neuromuscular Disease Care for Black People and People of Color

By Myrna Traylor | February 1, 2023